A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma, Open-Angle Eye Diseases Glaucoma Ocular Hypertension

Sex eligibility

All sexes

Study type

Observational

Primary location

Barcelona, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Glaucoma in one or both eyes

Exclusion criteria

Participation in a glaucoma therapeutic clinical trial

Treatment and study plan

Standard of care

Other

Patients with glaucoma treated with standard of care at the discretion of the physician. There is no specific treatment required for this study.

Primary outcomes

Change from Baseline in Visual Field

Time frame: Baseline, 24 Months

Secondary outcomes

Change from Baseline in Intraocular Pressure (IOP)

Time frame: Baseline, 24 Months

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start: 2009
Primary completion: 2013
Study completion: 2013
First posted: Jun 27, 2012
Registry last updated: Jun 20, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed